Angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blockers (ARBs) are primary line of medications for management of high blood pressure through inhibitory effect towards renin-angiotensin-aldosterone system (RAAS) [3]. This evidence concerns the gene REN and hypertensive disorder.